Predictors of anti-TNF treatment failure in anti-TNF-naive
5
$ 14.99
In stock
(645)
Product Description
Predictors of anti-TNF failure in Crohn
Alimentary Pharmacology & Therapeutics, Pharmacology Journal
Influence of first-line anti-TNF therapy on the effectiveness of adalimumab in ulcerative colitis: long-term clinical practice data - ILAPHAR
Anti-TNF-α biotherapies: perspectives for evidence-based personalized medicine
Dose-creep of Infliximab During Psoriasis Treatment: An Observational Study, HTML
The current state of the art for biological therapies and new small molecules in inflammatory bowel disease - Mucosal Immunology
Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases: Trends in Molecular Medicine
Full article: Infliximab to treat Crohn's disease: an update
Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease
Targeting Tumor Necrosis Factor Receptor 1 with Selected Aptamers for Anti-Inflammatory Activity
Biomedicines, Free Full-Text
IJMS, Free Full-Text
/cdn.vox-cdn.com/uploads/chorus_image/image/70309656/1360123621.0.jpg "TNF fantasy football start/sit advice, Week 16: 49ers-Titans on")
